Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd Waldman

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|April 24, 2019
Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progressionJung-Sik Kim, Xiaoyuan He, Jie Liu, et al.
Cancer Research|December 17, 2008
Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanomaDavid A Solomon, Jung-Sik Kim, Julia C Cronin, et al.
Gastroenterology|November 15, 2006
The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancerUlrike Stein, Franziska Arlt, Wolfgang Walther, et al.
Human Mutation|August 13, 2014
Mutational and functional analysis of the tumor-suppressor PTPRD in human melanomaVijay Walia, Todd D Prickett, Jung-Sik Kim, et al.
Urologic Oncology|March 13, 2021
STAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancerAnn Taber, Youngrok Park, Alana Lelo, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2012
Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapyEmmanuelle Huillard, Rintaro Hashizume, Joanna J Phillips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2018
STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder CancerAlana Lelo, Frederik Prip, Brent T Harris, et al.
Neuro-Oncology|June 20, 2012
p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cellsLing Cen, Brett L Carlson, Mark A Schroeder, et al.
Oncotarget|November 30, 2010
Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genesChristopher G Duncan, Patrick J Killela, Cathy A Payne, et al.
Science (New York, N.Y.)|August 20, 2011
Mutational inactivation of STAG2 causes aneuploidy in human cancerDavid A Solomon, Taeyeon Kim, Laura A Diaz-Martinez, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|April 24, 2019
Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progressionJung-Sik Kim, Xiaoyuan He, Jie Liu, et al.
Cancer Research|December 17, 2008
Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanomaDavid A Solomon, Jung-Sik Kim, Julia C Cronin, et al.
Gastroenterology|November 15, 2006
The metastasis-associated gene S100A4 is a novel target of beta-catenin/T-cell factor signaling in colon cancerUlrike Stein, Franziska Arlt, Wolfgang Walther, et al.
Human Mutation|August 13, 2014
Mutational and functional analysis of the tumor-suppressor PTPRD in human melanomaVijay Walia, Todd D Prickett, Jung-Sik Kim, et al.
Urologic Oncology|March 13, 2021
STAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancerAnn Taber, Youngrok Park, Alana Lelo, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2012
Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapyEmmanuelle Huillard, Rintaro Hashizume, Joanna J Phillips, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2018
STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non-Muscle-Invasive Bladder CancerAlana Lelo, Frederik Prip, Brent T Harris, et al.
Neuro-Oncology|June 20, 2012
p16-Cdk4-Rb axis controls sensitivity to a cyclin-dependent kinase inhibitor PD0332991 in glioblastoma xenograft cellsLing Cen, Brett L Carlson, Mark A Schroeder, et al.
Oncotarget|November 30, 2010
Integrated genomic analyses identify ERRFI1 and TACC3 as glioblastoma-targeted genesChristopher G Duncan, Patrick J Killela, Cathy A Payne, et al.
Science (New York, N.Y.)|August 20, 2011
Mutational inactivation of STAG2 causes aneuploidy in human cancerDavid A Solomon, Taeyeon Kim, Laura A Diaz-Martinez, et al.
Pageof 6